Cruise AI Control Tower for Pharma Logistics — Cold Chain and Compliance Exception Management in India

Pharma Logistics in India — Compliance, Cold Chain, and High-Value Cargo

Pharmaceutical logistics in India is defined by three non-negotiables: product integrity (cold chain compliance for temperature-sensitive products), regulatory compliance (GDP guidelines, documentation requirements), and cargo security (high-value APIs, finished formulations, and specialty drugs are targeted for theft and diversion).

Exception management in pharma logistics is not just an operational efficiency concern — it is a product quality and regulatory compliance concern. A temperature excursion on a biologics shipment, a route deviation on a high-value API truck, or a tracking gap during a controlled substance movement are events with regulatory and financial consequences beyond the immediate delivery.

Cold Chain Exception Management

Temperature-controlled pharma logistics — vaccines, biologics, insulin, certain APIs — requires continuous monitoring of vehicle temperature alongside location. Cruise integrates with cold chain monitoring sensors and triggers exceptions when:

• Temperature exceeds the defined range (both upper and lower breach)
• Reefer unit shows a fault signal or power interruption
• Dwell at a non-temperature-controlled location exceeds the configured safe window
• Tracking gap occurs on a cold chain shipment (unknown location = unknown temperature)

For cold chain breaches, Cruise triggers P1 escalation immediately — driver call, fleet manager, client QA team. The temperature breach event, duration, and recovery actions are logged for regulatory documentation.

Route Compliance on High-Value Pharma Lanes

High-value pharma shipments — API imports from ports, specialty drug distribution from manufacturing plants — are routed through approved corridors for security and compliance reasons. Route deviation on these lanes is not just an operational issue — it may trigger a GDP compliance investigation. Cruise's route deviation detection for pharma shipments is configured with tighter corridors and P1 classification for any deviation, with immediate notification to the client's QA and security teams.

Cargo Security for Controlled Substances

Controlled substance diversion is a documented risk in Indian pharma distribution. Cruise's combination of activity sensing, halt-location correlation, and tamper alert integration provides the in-transit monitoring layer that GDP guidelines require for high-risk shipments. Every exception is logged with complete documentation for regulatory audit purposes.

Compliance Documentation for Regulatory Audit

GDP compliance for pharma logistics requires documented evidence of monitoring, exception detection, and corrective actions taken. Cruise's automatic logging of every exception — detection time, escalation steps, resolution, temperature data if applicable — creates the documentation chain required for regulatory audits without manual record-keeping.

Distributor Delivery in Pharma Secondary Distribution

Secondary pharma distribution — from depot or C&F to stockist, hospital, and retail pharmacy — involves high stop counts and time-sensitive delivery windows. Cruise monitors stockist delivery dwell, delivery window compliance, and post-delivery confirmation. Vedika calls delivery executives to confirm delivery status at each stop where configured.